5AM Venture Management’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-56,725
| Closed | -$1.22M | – | 31 |
|
|
2025
Q1 | $1.22M | Hold |
56,725
| – | – | 0.46% | 29 |
|
|
2024
Q4 | $1.52M | Hold |
56,725
| – | – | 0.36% | 30 |
|
|
2024
Q3 | $610K | Hold |
56,725
| – | – | 0.13% | 28 |
|
|
2024
Q2 | $677K | Sell |
56,725
-1
| -0% | -$12 | 0.15% | 27 |
|
|
2024
Q1 | $1.04M | Hold |
56,726
| – | – | 0.23% | 26 |
|
|
2023
Q4 | $901K | Hold |
56,726
| – | – | 0.24% | 25 |
|
|
2023
Q3 | $1.07M | Hold |
56,726
| – | – | 0.31% | 26 |
|
|
2023
Q2 | $1.28M | Hold |
56,726
| – | – | 0.32% | 24 |
|
|
2023
Q1 | $1.44M | Hold |
56,726
| – | – | 0.37% | 23 |
|
|
2022
Q4 | $858K | Hold |
56,726
| – | – | 0.23% | 21 |
|
|
2022
Q3 | $712K | Hold |
56,726
| – | – | 0.14% | 21 |
|
|
2022
Q2 | $554K | Hold |
56,726
| – | – | 0.14% | 21 |
|
|
2022
Q1 | $945K | Hold |
56,726
| – | – | 0.21% | 19 |
|
|
2021
Q4 | $1.44M | Hold |
56,726
| – | – | 0.27% | 17 |
|
|
2021
Q3 | $2.54M | Sell |
56,726
-43,600
| -43% | -$1.95M | 0.52% | 15 |
|
|
2021
Q2 | $4.05M | Hold |
100,326
| – | – | 1.02% | 11 |
|
|
2021
Q1 | $5.34M | Hold |
100,326
| – | – | 0.96% | 9 |
|
|
2020
Q4 | $4.01M | Hold |
100,326
| – | – | 1.35% | 9 |
|
|
2020
Q3 | $5.72M | Hold |
100,326
| – | – | 1.5% | 9 |
|
|
2020
Q2 | $7.4M | Hold |
100,326
| – | – | 1.62% | 9 |
|
|
2020
Q1 | $4.98M | Hold |
100,326
| – | – | 1.54% | 8 |
|
|
2019
Q4 | $7.71M | Buy |
+100,326
| New | +$7.71M | 1.66% | 8 |
|